Influence of Plasma Cortisol and Other Laboratory Parameters on Nonalcoholic Fatty Liver Disease
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
Influence of Plasma Cortisol and Other Laboratory Parameters on Nonalcoholic Fatty Liver Disease ; volume:47 ; number:07 ; year:2014 ; pages:479-484
Hormone and metabolic research ; 47, Heft 07 (2014), 479-484
- Beteiligte Personen und Organisationen
-
Hubel, J. M.
Schmidt, S. A.
Mason, R. A.
Haenle, M. M.
Oeztuerk, S.
Koenig, W.
Boehm, B. O.
Kratzer, W.
Graeter, T.
Flechtner-Mors, M.
- DOI
-
10.1055/s-0034-1389982
- URN
-
urn:nbn:de:101:1-2018102513365435270780
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:38 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Hubel, J. M.
- Schmidt, S. A.
- Mason, R. A.
- Haenle, M. M.
- Oeztuerk, S.
- Koenig, W.
- Boehm, B. O.
- Kratzer, W.
- Graeter, T.
- Flechtner-Mors, M.
Ähnliche Objekte (12)
Non-alcoholic fatty liver disease
Artificial intelligence in nonalcoholic fatty liver disease
Insights into Nonalcoholic Fatty-Liver Disease Heterogeneity
Hepatic Innervations and Nonalcoholic Fatty Liver Disease
Multiomics study of nonalcoholic fatty liver disease
Role of bioactive fatty acids in nonalcoholic fatty liver disease
Liver fatty acid composition in mice with or without nonalcoholic fatty liver disease
Bioengineering liver microtissues for modeling non-alcoholic fatty liver disease
Pharmacological Treatment for Non-alcoholic Fatty Liver Disease
Nonalcoholic fatty liver disease, diet and gut microbiota
Nonalcoholic fatty liver disease and cardiovascular disease risk
Resveratrol inhibits nonalcoholic fatty liver disease in rats
Non-alcoholic fatty liver disease
Artificial intelligence in nonalcoholic fatty liver disease
Insights into Nonalcoholic Fatty-Liver Disease Heterogeneity
Hepatic Innervations and Nonalcoholic Fatty Liver Disease
Multiomics study of nonalcoholic fatty liver disease
Role of bioactive fatty acids in nonalcoholic fatty liver disease
Liver fatty acid composition in mice with or without nonalcoholic fatty liver disease
Bioengineering liver microtissues for modeling non-alcoholic fatty liver disease
Pharmacological Treatment for Non-alcoholic Fatty Liver Disease
Nonalcoholic fatty liver disease, diet and gut microbiota
Nonalcoholic fatty liver disease and cardiovascular disease risk
Resveratrol inhibits nonalcoholic fatty liver disease in rats
Non-alcoholic fatty liver disease
Artificial intelligence in nonalcoholic fatty liver disease
Insights into Nonalcoholic Fatty-Liver Disease Heterogeneity
Hepatic Innervations and Nonalcoholic Fatty Liver Disease
Multiomics study of nonalcoholic fatty liver disease
Role of bioactive fatty acids in nonalcoholic fatty liver disease
Liver fatty acid composition in mice with or without nonalcoholic fatty liver disease
Bioengineering liver microtissues for modeling non-alcoholic fatty liver disease
Pharmacological Treatment for Non-alcoholic Fatty Liver Disease
Nonalcoholic fatty liver disease, diet and gut microbiota
Nonalcoholic fatty liver disease and cardiovascular disease risk